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do the Editor: Transplantation of adult bone marrow– or blood-
erived autologous progenitor cells is a promising option for
reatment of patients with acute myocardial infarction or heart
ailure. Initial randomized, double-blind clinical trials demon-
trated encouraging results suggesting that cell therapy improves
eart function and patients’ prognosis (1,2). However, the mech-
nisms underlying the beneficial effects of cell therapy are discussed
ontroversially. Although most of the studies consistently reported
n improvement of neovascularization by physical formation of
apillaries and/or by paracrine effects (3), conflicting reports exist
egarding the capacity of progenitor cells to differentiate into
ardiomyocytes (4–7). Technical limitations leading to false-
ositive data have been accused of being at least in part responsible
or the controversial studies. Studying a patient with a well-defined
utation in the cardiac troponin T (TnT) gene offered the unique
pportunity to provide genetic proof for cardiac marker gene
xpression in patient-derived circulating cells after the induction of
ardiac differentiation in vitro.
For this purpose, peripheral blood was collected from a 2-year-old
atient with dilated cardiomyopathy caused by a heterozygous muta-
ion of troponin T located on 1q32 exon 9 (GA base exchange at
osition 8782) (8) (Online Fig. 1). The suspected mutation was
erified in the explanted heart of the patient, who finally underwent
eart transplantation after clinical decompensation. Circulating pro-
enitor cells (CPC) were isolated by Ficoll density centrifugation of
eripheral blood; mononuclear cells were incubated in endothelial
asal medium with growth factors as described for endothelial
rogenitor cells (7,9) and cultivated for 14 days ex vivo. Cardiac
ifferentiation was induced by a coculture system using neonatal
at cardiomyocytes as previously described (7,9). The CPC and
ardiomyocytes were cocultured on gelatin-coated dishes for 6
ays. Consistent with earlier reports, cocultured CPC expressed
he cardiac marker protein alpha-sarcomeric actinin as detected
y immunostaining (Online Fig. 2) and flow cytometry analysis
4.1  0.5% alpha-sarcomeric actinin/CM-Dil cells; n  5).
uantitative polymerase chain reaction (PCR) confirmed hu-
an TnT expression in cells after coculture with cardiomyo-
ytes. The level of human TnT expression in the coculture was
.6% compared with total human hearts (fluorescence intensity 4.58
0.68  d(F1)/dT in control human heart and 0.21  0.07 
(F1)/dT after coculture). To provide genetic evidence for cardiac
arker gene expression, cells were harvested and reverse transcrip-
ase (RT)-PCR was performed using human specific TnT primers.
hese primers were designed to span the region from exon 6 to exon
0 of human TnT to yield a 302-bp RT-PCR product (Online Fig.
). Control samples confirmed the absence of the RT-PCR product
hen genomic deoxyribonucleic acid was used (data not shown). The
02-bp RT-PCR product was subcloned using pGEM-Teasy vector,
nd 7 clones were sequenced. As shown in Figure 1, the sequences of
he cloned RT-PCR products were identical to human TnT exceptor the known GA mutation at position 8782 in 3 of the 7 clones
Online Fig. 3). The incidence of the mutation (43%) is in line with
he prediction of a heterozygous mutation.
To exclude cellular fusion between human CPC and neonatal rat
ardiomyocytes as a mechanism for the induction of cardiac gene
xpression in the coculture assay, we used cardiomyocytes for cocul-
ure that were fixed with 1% paraformaldehyde. Fixed cardiomyocytes
re unable to fuse but were previously shown to provide sufficient
nductive signals to induce cardiac commitment of adult progenitor
ells (7). After coculture of CPC with paraformaldehyde-fixed cardi-
myocytes for 6 days, expression of TnT was again analyzed by
T-PCR. Human TnT expression was also detected in CPC after
oculture with fixed cardiomyocytes as scaffold (Online Fig. 4),
ndicating that cardiac marker gene expression can occur indepen-
ently from cellular fusion. The cardiac differentiation of CPC
Full Sequence of mutated clones
GAAGAAGAAGAGGAAGCAAAGGAGGCTGAAGAT
GGCCCAATGGAGGAGTCCAAACCAAAGCCCAGGT
CGTTCATGCCCAACTTGGTGCCTCCCAAGATCCC
CGATGGAGAGAGAGTGGACTTTGATGACATCCAC
CGGAAGCGCATGAAGAAGGACCTGAATGAGTTGC
AGGCGCTGATTGAGGCTCACTTTGAGAACAGGAA
GAAAGAGGAGGAGGAGCTCGTTTCTCTCAAAGAC
AGGATCGAGAGACGTCGGGCAGAGCGGGCCGAG
CAGCAGCGCATCCGGAATGAGCGGGAGAAGGA
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Figure 1 RT-PCR of Human TnT After
Coculture of CPC With Rat Cardiomyocytes
Reverse transcriptase-polymerase chain reaction (RT-PCR) with ribonucleic acid
isolated from circulating progenitor cells (CPC) of 2 different donors after coculture
with neonatal rat cardiomyocytes (CM) for 6 days. (Top) The RT-PCR product from
the patient with the troponin T (TnT) mutation (donor A, green box) and the control
patient (donor B) is shown. The CM or CPC without coculture were used as control
samples to demonstrate the specificity of the human RT-PCR primers. The RT-PCR
against human GAPDH (h-GAPDH) was used as loading control. The green box in
the bottom panel indicates the sequence of the mutated TnT, with the primer
sequence indicated in blue and the mutation site in red.
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June 10, 2008:2289–90fter coculture with fixed cardiac myocytes was further confirmed
y detecting human messenger ribonucleic acid expression of the
ardiac markers Nkx2.5, MLC-2v, and ANP (Online Fig. 4).
In summary, these experiments provide undisputable genetic
vidence that circulating progenitor cells can be induced to express
ardiac-specific genes. Although the number of cells acquiring a
ardiac phenotype is rather low, the proof-of-concept that cardiac
ene expression can be induced opens the possibility of enhancing
ardiac differentiation capacity and thereby increasing the regen-
rative potential of circulating progenitor cells.
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